Merck signs MoU with CSIR-IICT to strengthen industry-academia ties
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments
A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern
Subscribe To Our Newsletter & Stay Updated